Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study
about
State of the Art: Newer biomarkers in heart failureEpidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentUtility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling PopulationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke.Cardiovascular biomarkers and sex: the case for women.Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis.ST2 and Galectin-3: Ready for Prime Time?Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.Biomarker-based risk prediction in the community.Relationship of galectin-3 with obesity, IL-6, and CRP in women.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study.Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals
P2860
Q27027899-BE620FCF-8CCE-48A8-AAAC-A257EAFFF2EFQ30251632-C18BF416-FA6A-4977-93E6-D8F62DDC474AQ33754895-29ABEECC-BDB3-49A5-8986-47F3BD2F6EEDQ35286926-22A3327C-370A-44C8-92E7-F952999799E6Q36956715-AEF94E8D-CBC6-4858-A6E1-55BDC8EDF93FQ37240346-401B50F1-2959-42BF-90B6-67F838875D31Q37599836-3B20DE1C-6961-410D-826A-347F79984D7EQ38543356-344AC17C-2C37-49F1-A96A-D26891E3AD4AQ38727409-FBAF9F28-C363-4D2F-A101-528DDB873D0FQ38816590-494AC5F0-EE5F-4C79-BD5B-E2841A63C7BEQ39017333-0AAEBD9F-0F1C-4757-B9C9-193A8C52D692Q39215627-52CE3530-766C-401C-B01B-6CECD7B1231AQ46298007-A4117CBC-BF2A-487F-9523-DA57F3363D06Q48159180-F51AC5DD-65E2-4325-B99B-248802B085ABQ55035022-D8900CBE-7C24-4A7C-BA88-FEFE6EBAF4D1Q57832125-A0541577-B70D-41FE-B2F5-73E0DAB6E2EB
P2860
Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@ast
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@en
Galectin-3 is independently as ...... se: The Rancho Bernardo Study.
@nl
type
label
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@ast
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@en
Galectin-3 is independently as ...... se: The Rancho Bernardo Study.
@nl
prefLabel
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@ast
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@en
Galectin-3 is independently as ...... se: The Rancho Bernardo Study.
@nl
P2093
P2860
P1476
Galectin-3 is independently as ...... ase: The Rancho Bernardo Study
@en
P2093
Alan S Maisel
Gail A Laughlin
Lori B Daniels
Paul Clopton
P2860
P304
P356
10.1016/J.AHJ.2013.12.031
P407
P577
2014-02-18T00:00:00Z